We are delighted to invite your practice to take part in the YouScreen self-sampling study. YouScreen is a unique opportunity to increase cervical screening uptake in your population by offering HPV self-sampling to non-attenders. YouScreen will integrate self-sampling, for the first time, into the NHS Cervical Screening Programme.
Self-sampling has been hailed as a ‘game-changer’ for cervical screening because it addresses most screening barriers by enabling women to take a cervical screening sample themselves, in private and at a time and place of their choosing (similar to chlamydia self-sampling). Self-samples also have similar accuracy to clinician samples.
YouScreen is running across 5 London boroughs where cervical screening coverage is particularly low (see Public Health Profiles 2018/2019); Camden (55.0%), Islington (63.1%), Barnet (63.9%), Newham (62.9%) and Tower Hamlets (60.1%).
The aims of the study are to:
- test a new pathway for the implementation of self-sampling for non-attenders within the NHS cervical screening programme in England
- provide the evidence-base that self-sampling can improve cervical screening coverage in England and can increase detection and treatment of high grade CIN (CIN2+)
The target population is women aged 25-64 years who are at least 6 months overdue their cervical screening. Eligible women will be identified and offered self-sampling kits via two methods:
- Opportunistic offer: identified via an EMIS alert and offered a kit by a healthcare professional when they consult for any reason
- Mail-out: identified via the national screening database NHAIS and posted a kit to their home address
Express your practice’s interest before 18 September 2020.
YouScreen self-sample results will be sent to the practice. Results will contribute towards your cervical screening QOF and CQC indicators and all participating practices will receive a minimum of £150 in NIHR payments.
Summary of GP Practice Involvement
Watch the GP video for more details.
If your practice decides to take part, here are a few steps your team must take:
- register your practice’s interest by completing the expression of interest form linked above before the 18 September 2020
- nominate a YouScreen Study Lead within your practice
- attend a 30-minute virtual training session
- GPs, Nurses and HCAs to offer kits opportunistically and manage results: HPV results will be received in the usual way from the CSL lab. HPV-positive women will require follow-up test (standard screening test i.e. clinician-taken sample)
- Monitor YouScreen kit stock
Further information is available on the NCL Cancer Alliance website, or by emailing the research team: